The Prevalence of Obesity For Schizophrenia Inpatients in Taiwan
Completed
- Conditions
- SchizophreniaObesity
- Registration Number
- NCT01170689
- Lead Sponsor
- TsaoTun Psychiatric Center, Department of Health, Taiwan
- Brief Summary
This study is the first hospital-based, cross-sectional study to discuss the prevalence of obesity among 710 inpatients with schizophrenia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 710
Inclusion Criteria
- diagnosis as ICD 295
- Living in rehabilitation ward during 2010/03/22~2010/04/02
Exclusion Criteria
none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body mass index (BMI) cross-sectional study, check one time
- Secondary Outcome Measures
Name Time Method waist circumference cross-sectional study, check for one time
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link antipsychotic medications to obesity in schizophrenia patients?
How does the prevalence of obesity in NCT01170689 compare to global schizophrenia inpatient populations?
Are there specific biomarkers associated with antipsychotic-induced weight gain in schizophrenia?
What adverse metabolic events are common in schizophrenia inpatients and how are they managed?
What combination therapies could address both schizophrenia and obesity in comorbid patients?
Trial Locations
- Locations (1)
Tsao-Tun Psychiatric Center
🇨🇳Nan-Tou, Taiwan
Tsao-Tun Psychiatric Center🇨🇳Nan-Tou, Taiwan